GlassScriptPhysician profile
Hwe Won Eugene Lee
NPI 1902473895
$959.52
in general payments reported to CMS, 2019-2025
7 companies · $611 in 2025
The $611 reported for 2025 was more than what 77% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $348 · 2025: $611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $909 · Education: $50.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $908.53 |
| Education | $50.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $336.81 | 2024-2025 | Remicade, Stelara, Tremfya |
| Abbvie INC. | $275.41 | 2024-2025 | |
| Janssen Biotech, INC. | $161.29 | 2025 | Tremfya |
| Ardelyx, INC. | $79.94 | 2024-2025 | Ibsrela |
| Medtronic, INC. | $65.37 | 2024 | Pillcam |
| Genzyme Corporation | $21.99 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $18.71 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hwe Won Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.